These findings suggest the utility of PEG-Lac-α-CDE (G3, DSC2, DSL1, DEP2) as a promising hepatocyte-specific siRNA delivery system, both in vitro and in vivo, and as a therapeutic approach for TTR-related amyloidosis [57]. The gene discussed is TTR; the disease is amyloidosis.